Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Neoleukin Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 25K | Jun 8, 2023 | Direct | ||
Seagen Inc. | Chief Financial Officer | Common Stock | 0 | $229.00 | Dec 14, 2023 | Direct | |
Seagen Inc. | Chief Financial Officer | Performance Stock Units | 0 | $229.00 | Dec 14, 2023 | Direct | |
Seagen Inc. | Chief Financial Officer | Restricted Stock Units | 0 | $229.00 | Dec 14, 2023 | Direct | |
Seagen Inc. | Chief Financial Officer | Stock Options (Right to Buy) | 0 | Dec 14, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SGEN | Seagen Inc. | Dec 14, 2023 | 27 | -$21.4M | 4 | Dec 15, 2023 | Chief Financial Officer |
SGEN | Seagen Inc. | Sep 21, 2023 | 1 | -$16.5K | 4 | Sep 22, 2023 | Chief Financial Officer |
SGEN | Seagen Inc. | Aug 31, 2023 | 1 | -$439K | 4 | Sep 1, 2023 | Chief Financial Officer |
SGEN | Seagen Inc. | Aug 28, 2023 | 2 | -$99.9K | 4 | Aug 30, 2023 | Chief Financial Officer |
SGEN | Seagen Inc. | Aug 15, 2023 | 4 | -$680K | 4 | Aug 17, 2023 | Chief Financial Officer |
NLTX | Neoleukin Therapeutics, Inc. | Jun 8, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
SGEN | Seagen Inc. | Apr 10, 2023 | 6 | -$8.76M | 4 | Apr 12, 2023 | Chief Financial Officer |
SGEN | Seagen Inc. | Apr 5, 2023 | 0 | $0 | 4/A | Apr 12, 2023 | Chief Financial Officer |
SGEN | Seagen Inc. | Apr 1, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Chief Financial Officer |
SGEN | Seagen Inc. | Mar 9, 2023 | 5 | -$5.62M | 4 | Mar 10, 2023 | Chief Financial Officer |
SGEN | Seagen Inc. | Feb 27, 2023 | 1 | -$3.65M | 4 | Feb 28, 2023 | Chief Financial Officer |
SGEN | Seagen Inc. | Feb 16, 2023 | 3 | -$4.83M | 4 | Feb 21, 2023 | Chief Financial Officer |
SGEN | Seagen Inc. | Aug 31, 2022 | 2 | -$646K | 4 | Sep 1, 2022 | Chief Financial Officer |
SGEN | Seagen Inc. | Aug 15, 2022 | 3 | -$335K | 4 | Aug 17, 2022 | Chief Financial Officer |
NLTX | Neoleukin Therapeutics, Inc. | May 12, 2022 | 1 | $0 | 4 | May 16, 2022 | Director |
SGEN | Seagen Inc. | Apr 20, 2022 | 1 | -$81.8K | 4 | Apr 22, 2022 | Chief Financial Officer |
SGEN | Seagen Inc. | Dec 20, 2021 | 1 | -$51.7K | 4 | Dec 22, 2021 | Chief Financial Officer |
SGEN | Seagen Inc. | Nov 3, 2021 | 5 | -$5.57M | 4 | Nov 5, 2021 | Chief Financial Officer |
SGEN | Seagen Inc. | Oct 29, 2021 | 3 | -$4.66M | 4 | Nov 2, 2021 | Chief Financial Officer |
SGEN | Seagen Inc. | Sep 23, 2021 | 1 | $33.4K | 4 | Sep 27, 2021 | Chief Financial Officer |
SGEN | Seagen Inc. | Aug 31, 2021 | 2 | -$668K | 4 | Sep 2, 2021 | Chief Financial Officer |
SGEN | Seagen Inc. | Aug 16, 2021 | 4 | -$82.4K | 4 | Aug 18, 2021 | Chief Financial Officer |
NLTX | Neoleukin Therapeutics, Inc. | May 11, 2021 | 1 | $0 | 4 | May 13, 2021 | Director |